Testing omalizumab for plant-food allergies
Treatments studied
Part of Immune system & allergy clinical trials.
This study tests a medication called omalizumab (a common allergy drug) to see if it can help people with severe allergies to plant foods like peach and melon, especially when standard treatments have failed. If you qualify, you may receive the drug and be monitored to see if your food allergies improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 55 years old.
- You have a confirmed allergy to plant foods like peach or melon, caused by specific proteins called LTP or profilin.
- You have had an allergic reaction during a supervised food challenge to peach (if you have an LTP allergy) or melon (if you have a profilin allergy), and also to at least one other food.
- If you have an LTP allergy, you have tried a special allergy treatment (immunotherapy) for peach that did not work.
- You are not pregnant, breastfeeding, or taking drugs that weaken the immune system.
- You do not have severe mental illness that would make it hard to follow the study, and you can stick to the visit schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new way to treat peach allergy using tiny microneedles. It aims to find better tests for diagnosing the allergy and to see if this treatment can help people build tolerance, so they can eat peaches safely.
This study compares doing a food challenge at home versus in a medical clinic for people who think they might be allergic to a food. If you are over 18 and your skin test to that food is negative, you may be able to join.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
This study gives a few doses of omalizumab (a medicine that blocks allergic reactions) and then does a food challenge to see if the patient can eat the food safely. It is for people who have already been prescribed this medicine for food allergy.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
Hear when a new Food Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.